InVyomma Plus: Advanced Gut Microbiome Test
InVyomma Plus

InVyomma Plus: Advanced Gut Microbiome Test

Gut microbiome profiling

Evaluate your gut microbiome and its association with cancer

The InVyomma Plus test provides a comprehensive gut health analysis by profiling the gut microbiome, the community of trillions of microorganisms that live within us and play a vital role in our overall health. By profiling these microorganisms and their metabolites, InVyomma Plus uncovers important connections between gut microbiota and cancer development, diagnosis, and treatment.

Emerging research shows that changes in the gut microbiome can influence inflammation, immune response, and even the effectiveness of cancer therapies.  The InVyomma Plus test facilitates deep microbiome analysis, empowering clinicians to explore these relationships by identifying dysbiosis (bacterial imbalances) and biomarkers linked to disease progression.

With this information, healthcare professionals can make more informed decisions about cancer prognosis, treatment options, and personalized care. Meanwhile, patients gain valuable insights into how the complex environment of their gastrointestinal tract and overall gut health may impact their cancer journey.

How does InVyomma Plus work?

InVyomma Plus integrates Next Generation Sequencing (NGS) with advanced bioinformatic algorithms.

The innovation lies in combining the results with a sophisticated algorithm and an expanding database that maps how microbes interact with the human host.

Additionally, the test is enhanced by measuring Short Chain Fatty Acids (SCFAs) in the stool sample, providing crucial insights into the balance and bacterial activity within the body.

Who should get an InVyomma Plus test?

The InVyomma Plus test is ideal for cancer patients who are undergoing cancer treatment. It equips clinicians with vital insights to enhance their decision-making regarding their patients' tumor prognosis, future treatment options, and overall well-being.

The test aids in diagnosing, confirming, or ruling out numerous pathological conditions associated with cancer. Furthermore, it provides valuable insights into the disease's etiology and pathogenesis, thereby aiding in the guidance of treatment strategies.

Test details

Sample type

Stool sample

Analysis period

≈ 2-3 weeks

Cancer type

Applicable for all cancer types

Final results

2-4 weeks after sample delivery

Sample size

4 collection tubes

Price*

790 €

* The prices of the tests may be an issue of local additional taxes and value added taxes which are dependent of each country’s legislation. The prices may vary in areas that are under the jurisdiction of a distributor. These prices are for the tests only, and they do not include in-office fees such as consultation, blood draws, etc.

* RGCC is not liable for any third-party comments or claims regarding our products. For accurate and up-to-date information about our offerings, please refer to our official website: rgcc-international.com

Contact us now for a comprehensive gut health analysis

For Healthcare Providers

  • Clinicians can reach out here to start providing the InVyomma Plus test 
  • Providers from our network can order the InVyomma Plus test here 
  • For general questions, contact us here 

For Patients

  • Learn about the ordering process for RGCC tests here
  • Find details on specific cancer types here
  • For general questions, contact us here

Use our "intelligent filter" to find out which test is most suitable for your patients.